ReviewJournal of neuro-oncology2022

Using chimeric antigen receptor T-cell therapy to fight glioblastoma multiforme: past, present and future developments.

David C Soler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.